Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Gouty Arthritis
NCT05332795Completed
- Sponsor
- Menoufia University
- Start
- Jun 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in gouty arthritis comparing Metformin with Placebo (2 arms). Primary endpoints: Serological remission criteria at 3 months, Articular remission criteria at 3 months and 1 more. Started Jun 2022; status: completed.
02
Drugs
metformin
03
Conditions
gouty arthritis
Beyond the preview
Go deeper on NCT05332795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05332795.